指南与共识流行病学与生物统计医学教育与科研方法

中国临床实践指南报告与方法学质量系统评价(2014-2018)

Clinical Epidemiology in China series. Paper 4: The reporting and methodological quality of Chinese clinical practice guidelines published between 2014 and 2018: A systematic review.
指南 / 共识 · J Clin Epidemiol · 2021-08-18

该研究系统检索多个数据库,纳入2014至2018年间中国制定的573部临床实践指南,采用AGREE II工具和RIGHT清单评价其方法学质量与报告质量。结果显示方法学质量平均总分为19.4%,报告质量平均总分为30.2%,均低于国际平均水平,但随时间有所改善。

要点

  • 中国指南方法学质量平均总分19.4%,报告质量平均总分30.2%,均低于国际平均水平。
  • 仅10.8%的指南使用GRADE方法,使用证据分级系统或报告资助的指南质量更高。
  • 指南质量随时间改善,但严谨性、应用性和编辑独立性等维度得分仍较低。

核心结论

  • 中国制定的临床实践指南方法学质量和报告质量随时间有所改善,但仍低于国际平均水平。

研究设计与样本

  • 系统评价,检索MEDLINE、Embase、CBM、CNKI和万方数据库,纳入2014至2018年中国制定的临床实践指南,最终纳入573部。
  • 使用AGREE II工具评价方法学质量,使用RIGHT清单评价报告质量。

主要发现

  • 共识别17188条记录,最终纳入573部指南;其中507部(88.5%)以中文发表,508部(88.7%)涉及西医。
  • 仅62部(10.8%)指南使用GRADE方法。
  • 方法学质量平均总分为19.4%,AGREE II各领域平均分:范围和目的28.6%,利益相关方参与17.0%,制定的严谨性11.7%,清晰性32.2%,应用性14.2%,编辑独立性12.8%。
  • 报告质量平均总分为30.2%,RIGHT各领域平均分:基本信息55.6%,背景43.8%,证据14.5%,推荐意见29.2%,评审和质量保证10.7%,资助和利益声明12.6%,其他信息8.4%。
  • 亚组分析发现,使用证据分级系统或报告接受资助的指南,其方法学质量和报告质量通常更高。

临床怎么用

  • 提示中国指南制定者应加强方法学严谨性、利益相关方参与、应用性和编辑独立性等薄弱环节。
  • 鼓励使用GRADE等证据分级系统并透明报告资助和利益声明,以提升指南质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to systematically review the methodological and reporting quality of clinical practice guidelines (CPGs) developed in China and published in medical journals between 2014 and 2018. STUDY DESIGN AND SETTING: We conducted a comprehensive search in multiple databases: MEDLINE (via PubMed), Embase, CBM (China Biology Medicine), CNKI (China National Knowledge Infrastructure) and Wanfang Data. We included all clinical practice guidelines developed in China between 2014 and 2018. The AGREE II tool and the RIGHT checklist were used to appraise the methodological quality and reporting quality of the included guidelines, respectively. RESULTS: We identified 17,188 records, and included finally 573 CPGs. Most (n=507, 88.5%) were published in Chinese, and 508 (88.7%) were about Western medicine. Only 62 (10.8%) of the guidelines used the GRADE approach. The mean overall score of methodological quality over all guidelines was 19.4%, and the mean scores for the AGREE II domains were 28.6% (Scope and purpose), 17.0% (Stakeholder involvement), 11.7% (Rigor of development), 32.2% (Clarity of presentation), 14.2% (Applicability) and 12.8% (Editorial independence). The mean overall score for reporting quality over all guidelines was 30.2%, with the following mean scores for each RIGHT domain: 55.6% (Basic information), 43.8% (Background), 14.5% (Evidence), 29.2% (Recommendations), 10.7% (Review and quality assurance), 12.6% (Funding and declaration of interest) and 8.4% (Other information). Subgroup analyses found that both the methodological and reporting quality were generally higher among CPGs that used evidence grading systems or reported receiving funding. CONCLUSION: Both the methodological quality and the reporting quality of CPGs developed in China have improved over time, but are still below the international average.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Zhou Q, Wang Z, Shi Q, et al. Clinical Epidemiology in China series. Paper 4: The reporting and methodological quality of Chinese clinical practice guidelines published between 2014 and 2018: A systematic review. J Clin Epidemiol. 2021. PMID: 34416326. doi:10.1016/j.jclinepi.2021.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。